Authors:
A. Owunwanne University of Rochester School of Medicine and Dentistry Rochester New York (USA)

Search for other papers by A. Owunwanne in
Current site
Google Scholar
PubMed
Close
,
R. O'Mara University of Rochester School of Medicine and Dentistry Rochester New York (USA)

Search for other papers by R. O'Mara in
Current site
Google Scholar
PubMed
Close
, and
C. O'Brien University of Rochester School of Medicine and Dentistry Rochester New York (USA)

Search for other papers by C. O'Brien in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

The in vivo and in vitro stability of99mTc hydroxyethlylidene diphosphonate, 99mTc methylenediphosphonate and99mTc pyrophosphate in plasma has been studied using paper chromatographic technique as the analytical tool. The results indicate that the amounts of99mTc activity found both at the origin and Rf range of99mTcO4 for in vivo experiments are slightly greater than those for either in vitro or control experiments. However, this amount of99mTc activity represents about 0.16–0.4% of the injected dose. Therefore, it is suggested that99mTc phosphorus radiopharmaceuticals are stable in vivo and neither oxidation nor hydrolysis of these bone imaging agents occurs in the blood.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)